Access cutting-edge diabetic foot infection treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access diabetic foot infection specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetic foot infection treatment provided free
TP-102 is a novel bacteriophage cocktail comprised of 5 (five) lytic bacteriophages against Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii. TP-102 is being developed for topical treatment of patients with wound infections including chronic ulcers; applied every other day (three times weekly (TIW)).
Sponsor: Technophage, SA
Check if you qualify for this diabetic foot infection clinical trial in Los Angeles, CA
If you're searching for diabetic foot infection treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic foot infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.